Opioid use during pregnancy co-occurs with other variables that are associated with worse outcomes in children, specifically maternal depression and the use of alcohol, tobacco, and other drugs.
Risk of Neonatal Opioid Withdrawal Syndrome More Common with Certain Opioids: Implications for Women with Opioid Use Disorder
More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.
Prenatal cannabis exposure was associated with persisting vulnerability to psychopathology throughout early adolescence.
Essential Reads: The Negative Impact of Prenatal Opioid Use on Fertility, Pregnancy, Neonatal Outcomes and Long-Term Developmental Outcomes
Prenatal opioid use is associated with increased maternal and infant mortality, prematurity, and poor neonatal outcomes.
Pregnant Women with Depression: Greater Use of Cannabis and Benzodiazepines, But Not Antidepressants
Cannabis use, as well as use of benzodiazepines and sedative-hypnotic medications, was more common in women with depression.
It is essential that clinicians, as well as those working in dispensaries, must educate women about the risks associated with cannabis use during pregnancy.
Several recent studies have examined patterns of opioid use in women receiving opioid prescriptions for pain management after delivery.
Our information on the use of medications for smoking cessation in nursing mothers is limited.
Parenting support, maternal bonding with the infant, engagement in an OUD treatment program, and recovery-specific support systems promoted recovery in postpartum women with opioid use disorders.
Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective means of identifying and intervening with patients whose patterns of use put them at risk for, or who already have, substance-related health problems.